The present invention discloses a cancer antigenpeptide comprising the following amino acid sequence: CysTyr Thr Trp Asn Gln Met Asn Leu (Sequence ID No. 3), acancer vaccine having this for its active ingredient, anda DNA vaccine having for its active ingredient DNA thatcodes for this peptide.